▼ SELL
$ Value
$9K
Shares
3,582
Price
$2
Filed
Mar 26
Insider
Name
Zindrick Thomas
Title
President and CEO
CIK
0001937573
Roles
Officer
Transaction Details
Transaction Date
2026-03-24
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
534,849
Footnotes
Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units.
Filing Info
Zindrick Thomas's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-24 | GNLX | ▼ | $9K |
| 2025-11-17 | GNLX | ▼ | $24K |
| 2025-09-01 | GNLX | D | — |
| 2025-09-01 | GNLX | A | — |
| 2025-09-01 | GNLX | D | — |
| 2025-09-01 | GNLX | A | — |
| 2025-09-01 | GNLX | D | — |
| 2025-09-01 | GNLX | A | — |
| 2025-09-01 | GNLX | D | — |
| 2025-09-01 | GNLX | A | — |
Other Insiders at GNLX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Yu Yong / Cappello Joseph
SVP, Clinical Development
|
— | $2K | 2026-03-24 |
| Thomas John | — | $29K | 2026-03-02 |
|
Smalling Ralph
Head of Regulatory
|
— | $1K | 2026-03-25 |